{
    "id": "15697659",
    "revid": "35591568",
    "url": "https://en.wikipedia.org/wiki?curid=15697659",
    "title": "Nefopam",
    "text": "Nefopam, sold under the brand name Acupan among others, is a centrally acting, non-&lt;a href=\"opioid\"&gt;opioid&lt;/a&gt; &lt;a href=\"analgesic\"&gt;painkilling medication&lt;/a&gt;, that is primarily used to treat moderate to severe pain.\nNefopam acts in the brain and spinal cord to relieve pain via novel mechanisms: &lt;a href=\"antinociceptive\"&gt;antinociceptive&lt;/a&gt; effects from triple monoamine reuptake inhibition, and &lt;a href=\"antihyperalgesic\"&gt;antihyperalgesic&lt;/a&gt; activity through modulation of &lt;a href=\"glutamatergic\"&gt;glutamatergic&lt;/a&gt; transmission.\nMedical uses.\nNefopam is effective for prevention of shivering during surgery or recovery from surgery. Nefopam was significantly more effective than &lt;a href=\"aspirin\"&gt;aspirin&lt;/a&gt; as an analgesic in one clinical trial, although with a greater incidence of side effects such as sweating, dizziness and nausea, especially at higher doses. The estimated relative potency of nefopam to morphine indicates that 20\u00a0mg of nefopam HCl is the approximate analgesic equal of 12\u00a0mg of morphine with comparable analgesic efficacy to morphine, or &lt;a href=\"oxycodone\"&gt;oxycodone&lt;/a&gt;, while nefopam tends to produce fewer side effects, does not produce respiratory depression, and has much less &lt;a href=\"drug%20abuse\"&gt;abuse&lt;/a&gt; potential, and so is useful either as an alternative to opioid analgesics, or as an adjunctive treatment for use alongside opioids or other types of analgesics. Nefopam is also used to treat severe &lt;a href=\"hiccups\"&gt;hiccups&lt;/a&gt;.\nContraindications.\nNefopam is contraindicated in people with convulsive disorders, those that have received treatment with irreversible &lt;a href=\"monoamine%20oxidase%20inhibitors\"&gt;monoamine oxidase inhibitors&lt;/a&gt; such as &lt;a href=\"phenelzine\"&gt;phenelzine&lt;/a&gt;, &lt;a href=\"tranylcypromine\"&gt;tranylcypromine&lt;/a&gt; or &lt;a href=\"isocarboxazid\"&gt;isocarboxazid&lt;/a&gt; within the past 30 days and those with &lt;a href=\"myocardial%20infarction\"&gt;myocardial infarction&lt;/a&gt; pain, mostly due to a lack of safety data in these conditions.\nSide effects.\nCommon side effects include nausea, nervousness, dry mouth, light-headedness and &lt;a href=\"urinary%20retention\"&gt;urinary retention&lt;/a&gt;. Less common side effects include vomiting, blurred vision, drowsiness, sweating, insomnia, headache, confusion, hallucinations, tachycardia, aggravation of angina and rarely a temporary and benign pink discolouration of the skin or &lt;a href=\"erythema%20multiforme\"&gt;erythema multiforme&lt;/a&gt;.\nOverdose.\n&lt;a href=\"Overdose\"&gt;Overdose&lt;/a&gt; and death have been reported with nefopam. Overdose usually manifests with &lt;a href=\"convulsion\"&gt;convulsion&lt;/a&gt;s, &lt;a href=\"hallucination\"&gt;hallucination&lt;/a&gt;s, &lt;a href=\"tachycardia\"&gt;tachycardia&lt;/a&gt;, and &lt;a href=\"hyperdynamic%20circulation\"&gt;hyperdynamic circulation&lt;/a&gt;. Treatment is usually supportive, managing cardiovascular complications with &lt;a href=\"beta%20blockers\"&gt;beta blockers&lt;/a&gt; and limiting absorption with &lt;a href=\"activated%20charcoal\"&gt;activated charcoal&lt;/a&gt;.\nInteractions.\nIt has additive anticholinergic and sympathomimetic effects with other agents with these properties. Its use should be avoided in people receiving some types of antidepressants (&lt;a href=\"tricyclic%20antidepressants\"&gt;tricyclic antidepressants&lt;/a&gt; or &lt;a href=\"monoamine%20oxidase%20inhibitors\"&gt;monoamine oxidase inhibitors&lt;/a&gt;) as there is the potential for &lt;a href=\"serotonin%20syndrome\"&gt;serotonin syndrome&lt;/a&gt; or &lt;a href=\"hypertensive%20crises\"&gt;hypertensive crises&lt;/a&gt; to result.\nPharmacology.\nThe &lt;a href=\"mechanism%20of%20action\"&gt;mechanism of action&lt;/a&gt; of nefopam and its &lt;a href=\"analgesic\"&gt;analgesic&lt;/a&gt; effects are not well understood, although &lt;a href=\"reuptake%20inhibitor\"&gt;inhibition&lt;/a&gt; of the &lt;a href=\"reuptake\"&gt;reuptake&lt;/a&gt; of &lt;a href=\"serotonin\"&gt;serotonin&lt;/a&gt;, &lt;a href=\"norepinephrine\"&gt;norepinephrine&lt;/a&gt;, and to a lesser extent &lt;a href=\"dopamine\"&gt;dopamine&lt;/a&gt; (that is, acting as an ) is thought to be involved. It also reduces &lt;a href=\"glutamate\"&gt;glutamate&lt;/a&gt; signaling via modulating &lt;a href=\"sodium%20channel\"&gt;sodium&lt;/a&gt; and &lt;a href=\"calcium%20channels\"&gt;calcium channels&lt;/a&gt;.\nPharmacokinetics.\nThe &lt;a href=\"absolute%20bioavailability\"&gt;absolute bioavailability&lt;/a&gt; of nefopam is low. It is reported to achieve therapeutic plasma concentrations between 49 and 183\u00a0nM. The drug is approximately 73% &lt;a href=\"plasma%20protein%20binding\"&gt;protein-bound&lt;/a&gt; across a plasma range of 7 to 226\u00a0ng/mL (28\u2013892\u00a0nM). The &lt;a href=\"metabolism\"&gt;metabolism&lt;/a&gt; of nefopam is &lt;a href=\"hepatic\"&gt;hepatic&lt;/a&gt;, by \"N\"-&lt;a href=\"demethylation\"&gt;demethylation&lt;/a&gt; and via other &lt;a href=\"metabolic%20route\"&gt;routes&lt;/a&gt;. Its &lt;a href=\"terminal%20half-life\"&gt;terminal half-life&lt;/a&gt; is 3 to 8 hours, while that of its &lt;a href=\"active%20metabolite\"&gt;active metabolite&lt;/a&gt;, desmethylnefopam, is 10 to 15 hours. It is &lt;a href=\"elimination%20%28pharmacology%29\"&gt;eliminated&lt;/a&gt; mostly in &lt;a href=\"urine\"&gt;urine&lt;/a&gt;, and to a lesser extent in &lt;a href=\"feces\"&gt;feces&lt;/a&gt;.\nChemistry.\nNefopam is a &lt;a href=\"cyclic%20compound\"&gt;cyclized&lt;/a&gt; &lt;a href=\"structural%20analogue\"&gt;analogue&lt;/a&gt; of &lt;a href=\"orphenadrine\"&gt;orphenadrine&lt;/a&gt;, &lt;a href=\"diphenhydramine\"&gt;diphenhydramine&lt;/a&gt;, and &lt;a href=\"tofenacin\"&gt;tofenacin&lt;/a&gt;, with each of these compounds different from one another only by the presence of one or two &lt;a href=\"carbon\"&gt;carbon&lt;/a&gt;s. The &lt;a href=\"ring%20system%20%28chemistry%29\"&gt;ring system&lt;/a&gt; of nefopam is a &lt;a href=\"benzoxazocine\"&gt;benzoxazocine&lt;/a&gt; system.\nSociety and culture.\nRecreational use.\nRecreational use of nefopam has rarely been reported, and is far less common than with opioid analgesics.\nNames.\nIn the 1960s, when it was first developed, it had the generic name fenazoxine."
}